Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-723-7299
Dr. Day is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Neurology, 1983 - 1986
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1982 - 1983
University of Minnesota Medical SchoolClass of 1977
Certifications & Licensure
CA State Medical License 2011 - 2027
MN State Medical License 1992 - 2022
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others Start of enrollment: 2010 Apr 01
- A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
- Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Start of enrollment: 2015 Jun 30
Publications & Presentations
PubMed
- KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS.Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke
JCI Insight. 2026-03-26 - MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility.Janel A M Peterson, Jesus A Frias, Andrew N Miller, Krishnakant G Soni, Yi Zhang
Proceedings of the National Academy of Sciences of the United States of America. 2025-12-16 - Generation of two induced pluripotent stem cell lines from patients with Facioscapulohumeral muscular dystrophy.Ravichandra Venkateshappa, Francesca Vacante, Lingyun Xu, Gabriela Canel-Rivero, John W Day
Stem Cell Research. 2025-09-01
Journal Articles
- Telomere Shortening Is a Hallmark of Genetic CardiomyopathiesChristine E Seidman, John T Hinson, Gerhard Weber, Euan Ashley, John W Day, Joseph C Wu, Proceedings of the National Academy of Sciences
Press Mentions
FDA Approves Itvisma for Spinal Muscular AtrophyDecember 8th, 2025- Itvisma Wins FDA Approval as Novartis’ Second SMA Gene TherapyNovember 25th, 2025
- Smartphones Can Monitor Patients with Neuromuscular DiseasesNovember 3rd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
